Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Director departure
Quarterly results
CC transcript
|
|
BIO REFERENCE LABORATORIES INC (BRLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/19/2021 |
GN
| Brilliant Acquisition Corporation: New SEC Guidance Relating to SPAC Warrants, Its Effect on the Company's Periodic Filings and Compliance with Nasdaq Rules |
| 07/20/2020 |
GN
| Brilliant Acquisition Corporation Announces Separate Trading of its Ordinary Shares, Rights, and Warrants, Commencing July 22, 2020 |
| 06/30/2020 |
GN
| Brilliant Acquisition Corporation Announces Full Exercise of Overallotment Option |
| 06/26/2020 |
GN
| Brilliant Acquisition Corporation Announces Closing of $40 Million Initial Public Offering |
| 06/23/2020 |
GN
| BRILLIANT ACQUISITION CORPORATION ANNOUNCES PRICING OF $40 MILLION INITIAL PUBLIC OFFERING |
| 09/12/2012 |
PRN
| IncellDx, Inc. gibt Zusammenarbeit mit BioReference Laboratories, Inc. bekannt, um Studie mit 10.000 Proben unter Verwendung eines Pap-Tests ohne Objektträger durchzuführen |
| 08/18/2011 |
BW
| BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter, Fiscal Year 2011 |
| 06/08/2011 |
BW
| BioReference Laboratories, Inc to Speak at William Blair & Company???s 31st Annual Growth Stock Conference |
| 05/31/2011 |
BW
| BioReference Laboratories, Inc. to Speak at the 2011 Jefferies Global Healthcare Conference |
| 05/26/2011 |
BW
| CORRECTING and REPLACING Bio-Reference Laboratories, Inc. Reports Record Quarterly Success |
| 05/26/2011 |
BW
| CORRECTING and REPLACING Bio-Reference Laboratories, Inc. Reports Record Quarterly Success |
| 05/19/2011 |
BW
| BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2011 |
| 05/03/2011 |
BW
| BioReference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care Conference |
| 03/03/2011 |
BW
| BioReference Laboratories, Inc. Reports 23% Revenue, 20% Patient Count Increase in Solid Quarterly Results |
| 02/24/2011 |
BW
| BioReference Laboratories, Inc. Announces Earnings Date for First Quarter for Fiscal Year 2011 |
| 12/09/2010 |
BW
| BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2010 |
| 11/10/2010 |
BW
| BioReference Laboratories, Inc. to Speak at the Lazard Capital Markets 7th Annual Healthcare Conference |
|
|